DSS, INC. - 22 May 2025 Form 4 Insider Report for IMPACT BIOMEDICAL INC. (IBO)

Role
10%+ Owner
Signature
/s/ Jason Grady
Issuer symbol
IBO
Transactions as of
22 May 2025
Net transactions value
-$88,006
Form type
4
Filing time
06 Jan 2026, 17:25:05 UTC
Previous filing
07 Apr 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DSS, INC. 10%+ Owner 275 WIREGRASS PKWY, HENRIETTA /s/ Jason Grady 06 Jan 2026 0000771999

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBO Common Stock Sale $63,476 -115,600 -16% $0.5491 590,424 22 May 2025 Direct
transaction IBO Common Stock Sale $24,530 -45,400 -7.7% $0.5403 545,024 27 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This entity is a wholly-owned subsidiary of DSS, Inc. This amendment filing corrects an error in connection with the number of total shares of Common Stock that DSS, Inc. beneficially owns of IBO from its previously filed Form 4 on May 27, 2025. This corrected amendment includes DSS' correct beneficial ownership of IBO, which includes 545,024 shares of IBO's common stock pursuant to the Celios Asset sale.